Manuel Kadre - 02 Oct 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Reporting relationship: Director
Issuer ticker: NEUE
Reported as of: 02 Oct 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Oct 2025, 18:26:02 UTC
Prior SEC filing: 16 Jul 2025
Next SEC filing: 17 Oct 2025
Source filing: View source filing
Reporting owner signature: /s/ Eric Halverson for Manuel Kadre, Attorney-in-Fact

Key filing fact

Manuel Kadre filed Form 4 for NeueHealth, Inc. (NEUE) on 06 Oct 2025.

Key facts

This page summarizes Manuel Kadre's Form 4 filing for NeueHealth, Inc. (NEUE).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 06 Oct 2025, 18:26.

Change

Previous filing in this sequence was filed on 16 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001396538 Primary reporting owner

Kadre Manuel

Relationship: Director
Address: C/O NEUEHEALTH, INC., 9250 NW 36TH ST SUITE 420, DORAL
Signature: /s/ Eric Halverson for Manuel Kadre, Attorney-in-Fact
Signature date: 06 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEUE transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -29,755
Change %: -100%
Price
Shares after: 0
Date: 02 Oct 2025
Ownership: Direct
Footnotes: F1, F2

NEUE transaction

Common Stock

Disposed to Issuer

Transaction value
Shares: -3,750
Change %: -100%
Price
Shares after: 0
Date: 02 Oct 2025
Ownership: Kadre Family Partnership, L.P.
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Manuel Kadre is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 3 footnotes

Footnote F1

On October 2, 2025, NH Holdings 2025, Inc. ("Parent"), acquired the Issuer pursuant to a certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and NH Holdings Acquisition 2025, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), dated as of December 23, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, the Issuer merged with and into Merger Sub, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). Parent and Merger Sub are indirectly controlled by private investment funds affiliated with New Enterprise Associates, Inc.

Footnote F2

Pursuant to the Rollover Agreement, dated as of September 9, 2025 (the "Rollover Agreement"), entered into by and among NH Holdings 2025 SPV, L.P. ("Holdings"), NH Holdings 2025, Inc., NH Holdings Acquisition 2025, Inc. and the Reporting Person, the Reporting Person contributed its shares of Issuer common stock, Series A Convertible Perpetual Preferred Stock ("Series A Preferred Stock") and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") to Holdings in exchange for Holdings common units, series A preferred units and series B preferred units on a one for one basis in accordance with the Rollover Agreement, and effective as of the effective time of the Merger (the "Effective Time").

Footnote F3

Reflects securities held by the Kadre Family Partnership, L.P. a family limited partnership, of which the Reporting Person is the general partner.